Resultats de la cerca - Milind Javle

Refinar resultats
  1. 1
    Molecular profiling of biliary tract cancer: a target rich disease

    Molecular profiling of biliary tract cancer: a target rich disease per Apurva Jain, Milind Javle

    Publicat 2016
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    The role of PARP in DNA repair and its therapeutic exploitation

    The role of PARP in DNA repair and its therapeutic exploitation per Milind Javle, Nicola J. Curtin

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma

    Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma per Yun Shin Chun, Milind Javle

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer

    Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer per Milind Javle, Elizabeth Smyth, Ian Chau

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Systemic therapy for gallbladder cancer

    Systemic therapy for gallbladder cancer per Milind Javle, Haitao Zhao, Ghassan K. Abou‐Alfa

    Publicat 2019
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  6. 6
    Nuclear or cytoplasmic expression of survivin: What is the significance?

    Nuclear or cytoplasmic expression of survivin: What is the significance? per Fengzhi Li, Jie Yang, Nithya Ramnath, Milind Javle, Dongfeng Tan

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of<i>FGFR</i>-Aberrant Tumors

    Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of<i>FGFR</i>-Aberrant Tumors per Milind Javle, Gentry Teng King, Kristen Spencer, Mitesh J. Borad

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Single Nucleotide Polymorphisms of Gemcitabine Metabolic Genes and Pancreatic Cancer Survival and Drug Toxicity

    Single Nucleotide Polymorphisms of Gemcitabine Metabolic Genes and Pancreatic Cancer Survival and Drug Toxicity per Taro Okazaki, Milind Javle, Motofumi Tanaka, James L. Abbruzzese, Donghui Li

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice

    FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice per Anuhya Kommalapati, Sri Harsha Tella, Mitesh J. Borad, Milind Javle, Amit Mahipal

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer

    Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer per Motofumi Tanaka, Milind Javle, Xiaoqun Dong, Cathy Eng, James L. Abbruzzese, Donghui Li

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer

    Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer per Milind Javle, Yanan Li, Dongfeng Tan, Xiaoqun Dong, Ping Chang, Siddhartha Kar, Donghui Li

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    The inflammatory inception of gallbladder cancer

    The inflammatory inception of gallbladder cancer per Jaime A. Espinoza, Carolina Bizama, Patricia García, Catterina Ferreccio, Milind Javle, Juan Francisco Miquel, Jill Koshiol, Juan Carlos Roa

    Publicat 2016
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  13. 13
    Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference

    Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference per Gonzalo Sapisochín, Milind Javle, Jan Lerut, Masayuki Ohtsuka, R. Mark Ghobrial, Taizo Hibi, Nancy Man Kwan, Julie K. Heimbach

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    Gallbladder Cancer: expert consensus statement

    Gallbladder Cancer: expert consensus statement per Thomas A. Aloia, Nicolás Jarufe, Milind Javle, Shishir K. Maithel, Juan Carlos Roa, Volkan Adsay, Felipe José Fernández Coimbra, William R. Jarnagin

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

    Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma per Reham Abdel‐Wahab, Gauri R. Varadhachary, Priya Bhosale, Xuemei Wang, David R. Fogelman, Rachna T. Shroff, Michael J. Overman, Robert A. Wolff, Milind Javle

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer

    Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer per Morten Lapin, Satu Oltedal, Kjersti Tjensvoll, Tove Buhl, Rune Smaaland, Herish Garresori, Milind Javle, Nils Glenjen, B.K. Abelseth, Bjørnar Gilje, Oddmund Nordgård

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Next‐generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance

    Next‐generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance per Daniel H. Ahn, Milind Javle, Chul Ahn, Apurva Jain, Sameh Mikhail, Anne M. Noonan, Christina Wu, Rachna T. Shroff, James L. Chen, Tanios Bekaii‐Saab

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma

    Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma per Nawapol Kunkeaw, Sung Ho Jeon, K Lee, Betty H. Johnson, S. Tanasanvimon, Milind Javle, Chawalit Pairojkul, Yaovalux Chamgramol, Wipaporn Wongfieng, Bin Gong, Chanvit Leelayuwat, Y S Lee

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study

    Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study... per Pat Gulhati, Kanwal Raghav, Rachna T. Shroff, Gauri R. Varadhachary, Scott Kopetz, Milind Javle, Wei Qiao, Huamin Wang, Jeffrey S. Morris, Robert A. Wolff, Michael J. Overman

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline <i>BRCA</i> Variants

    Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline <i>BRCA</i> Variants per Milind Javle, Einat Shacham‐Shmueli, Lianchun Xiao, Gauri Varadhachary, Naama Halpern, David R. Fogelman, Ben Boursi, Syeda Uruba, Ofer Margalit, Robert A. Wolff, Talia Golan

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: